上海莱士：目前，广西莱士处于试生产阶段，待完成试生产及药品注册审批后，将逐步提升产量

Core Viewpoint - The company is currently in the trial production phase at its Guangxi facility and aims to gradually increase production capacity after completing trial production and drug registration approval [2]. Group 1: Company Operations - Guangxi facility is in trial production stage and will enhance output once trial production and drug registration are completed [2]. - The company emphasizes that the blood products industry has unique characteristics, with production capacity primarily influenced by plasma collection capabilities and regulatory approvals [2]. - The company is committed to expediting the approval process for Guangxi products to achieve stable operations [2].